Market Report, "Digestive Remedies in Norway", published
New Consumer Goods research report from Euromonitor International is now available from Fast Market Research
[ClickPress, Sun Apr 12 2015] Changing lifestyle patterns continued to affect value sales of digestive remedies in 2014. Primarily, Norwegians live more active and hectic lives, combining travel and sports with career and family. Consequently, as the frequency of travel increases so did the sales of motion sickness remedies. Furthermore, hectic lifestyles tend to bring an increase in incidence of ulcers and heartburn, resulting in rising sales of antacids. Lastly, an ageing Norwegian population supported growth of digestive remedies, where, for example, laxatives was predominantly driven by the elderly.
Full Report Details at
Johnson & Johnson Consumer Nordic continues to lead value sales of digestive remedies with an 18% value share in 2014. Digestive remedies is highly fragmented where all other players have a value share of 10% or less. Johnson & Johnson has more than five different products: Mircolax, Pepcid, Imodium, Imodium Comp and Imogas, spanning more than four different main product areas and leading in value sales in two of them ie diarrhoeal remedies and H2 Blockers. Strong brand names such as Imodium and Pepcid are well-known both in Norway and abroad, which benefited the company.
Delivery problems with Pepcid Duo in Norway during the review period considerably changed the dynamics of H2 blockers. The brand went from a 62% value share in 2009 to negligible size in 2013. The drastic contraction in sales was due to relocation of the manufacturing plant from the US to Europe and regulation arising from that move. Pepcid Duo is expected to be re-launched in Norway in 2015 which will result in changes to the competitive landscape. However, it is possible that it will be difficult for the brand to regain the position it once had given that other brands gained acceptance among Norwegian consumers.
Discover the latest market trends and uncover sources of future market growth for the Digestive Remedies industry in Norway with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Digestive Remedies industry in Norway, our research will save you time and money while empowering you to make informed, profitable decisions.
The Digestive Remedies in Norway market research report includes:
* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)
You may also be interested in these related reports:
- Digestive Remedies in the United Kingdom
- Digestive Remedies in South Korea
- Digestive Remedies in Ukraine
- Digestive Remedies in the United Arab Emirates
- Digestive Remedies in Bosnia-Herzegovina